Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Keynote lecture: Mutation signatures and targeting the DNA damage response

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.10.18
Views: 788

Prof Thomas Helleday - Sheffield Cancer Centre, Sheffield, UK

Prof Thomas Helleday speaks with ecancer at ESMO 2018 in Munich about mutation signatures and targeting the DNA damage response.

Prof Helleday explains that whole genome sequencing now allows us to have a greater understanding of mutations and rearrangements rather than using a single mutation as was the historical process.

He also describes how immunocology drugs are benefitting, with a refined method allowing for a more tailored treatment.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Donate to ecancer

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation